BCLI
Brainstorm Cell Therapeutics Inc.
Set alert
- YTD
- +56.38%
- 1 year
- +32.32%
- Open
- 0.8703
- Prev close
- 0.90875
- Mkt cap
- 9.49M
- Vol
- 3.48K
- Avg vol
- 23.42K
- EPS
- -0.93
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.856
- High
- 0.943
- Forward P/E
- -0.91
- Beta
- 0.39
- Short ratio
- 1.25
- Inst. own
- 13.90%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.70
- 200-d avg
- 4.88
- 1y target
- 23.45
Discussion (18)
Sign in to join the discussion
Could be in play next week. Volume precedes price.
Can’t believe I wimped out and sold all my shares just before close. Missed out on a quick 50%
Sold all my shares just before close ?
27/09/2023 ET
NurOwn BCLI $0.96
Advisory Committee meeting planned for September 27, 2023. PDUFA data planned for December 8, 2023. Phase 3 trial did not meet primary endpoint - November 17, 2020. Refusal to File letter received November 10, 2022.
$BCLI I can smell 3 by next week.
$BCLI 2.50 is it possible today?
$BCLI resubmit BLA NurOwn technology platform used to produce autologous.
$BCLI great price to starting position right here.
356678 Change your life forever with Dekmartrades! 7 day free trial! https://tradecaster.com/home?afmc=4o